Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EBIT Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -14.6481.56139.20-22.3865.42

What is the latest EBIT Growth ratio of NEULAND LABORATORIES ?

The latest EBIT Growth ratio of NEULAND LABORATORIES is -14.64 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-14.64
Mar202481.56
Mar2023139.20
Mar2022-22.38
Mar202165.42

How is EBIT Growth of NEULAND LABORATORIES Trending?

Years EBIT Growth % Change
Mar2025 -14.64
Negative
Mar2024 81.56
-41.41
Mar2023 139.2
Positive
Mar2022 -22.38
Negative
Mar2021 65.42 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EBIT Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,852.4 Cr 9.6% 1% 3.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -5.7% -3.3% -2.1% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -3.1% -9.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -6.1% -8.3% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -5.1% -6% 4.8% Stock Analytics
CIPLA ₹97,115.7 Cr -3.3% -11.2% -19.5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

9.6%

1%

3.4%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses